P-glycoprotein/MDR1 (P-gp) is a well characterised membrane transporter relevant in drug disposition and multi-drug resistance. In this study, we aimed to investigate in how far nanoparticulates impair the function of the P-gp transport system, and which particle properties govern these interactions.
Introduction
The use of nanotechnologies has expanded rapidly during the last decade and begins to revolutionise the scientific landscape as well as everyday's life. Nanoparticles, nanometre-ranged drug delivery systems, offer opportunities across all areas of medical treatment. Significant advances in cancer diagnostics, imaging and therapy have been developed based on the nanomedicine approach [1, 2] . To improve the biodistribution of (particularly anti-cancer) drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. In addition, active targeting strategies using surface-bound ligands directed against selected cellular targets amplify the specificity of these therapeutic nanocarriers [3, 4] .
It has also been suggested that nanoparticles have the ability to accumulate in cells without being recognised by P-glycoprotein, one of the main mediators of multidrug resistance, resulting in the increased intracellular concentration of drugs [5] .
Nevertheless, at present we are only beginning to understand the opportunities, challenges and potential hazards of nanomaterials [6] . P-glycoprotein/MDR1 (P-gp) is a 170-kDa membrane glycoprotein encoded by the ABCB1 gene. It is known to play an important role as an efflux pump in drug disposition, particularly in cancer chemotherapy [7] . P-gp is also expressed in many tissues under physiological conditions, indicating its major role in cellular transport of a variety of endogenous substrates and therapeutic agents [8, 9] . Presently, more than 100 compounds have been identified to be P-gp substrates, of which the majority were basic lipophilic amines [10] . The lung is thought to accumulate lipophilic amines, which strongly suggests that P-gp-mediated efflux plays an important role in pulmonary drug accumulation [11, 12] . Interestingly, recent studies on the impact of P-gp on drug disposition after oral inhalation in vivo and in situ have resulted in quite conflicting data, making this an exiting area for further investigations [13, 14] .
In this study, we aimed to investigate in how far nanoparticulates impair the function of the P-gp transport system and which particle properties govern these interactions.
Commercially available, insoluble latex nanoparticles with various surface and size characteristics were studied in an in vitro model of human alveolar epithelial type 2-like cells, A549.
Materials and Methods

Materials
A549 cells (ATCC CL-185) were obtained from LGC Promochem (Teddington, UK).
All cell culture plastics were obtained from Greiner (Frickenhausen, Germany), with the exception of Lab-Tek chamber slides (Nunc, Roskilde, Denmark). Nanoparticles (L3405, L3280, LB1, L9902 and L0780), mouse monoclonal anti-P-gp antibody (clone F4) and all other chemicals and reagents were purchased from Sigma-Aldrich (Dublin, Ireland). Type Culture Collection CL-185; LGC Promochem, Teddington Middlesex, UK) cells are derived from a human pulmonary adenocarcinoma [15] . Due to phenotypic similarity to type II alveolar epithelial cells, this cell line has been widely utilised in studies of alveolar epithelium function [16] . Cells of passage numbers 66 to 82 were used in this study and were maintained in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's nutrient mixture F-12 (DMEM:F-12) supplemented with 5% (v/v) FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were cultured at 37°C in 5% CO 2 atmosphere and culture medium was exchanged every 48 h.
Cell culture
A549 (American
Rhodamine 123 release studies
Rhodamine 123 (Rh123) release studies were performed using A549 cell monolayers cultured for 5 days in 24-well plates at a density of 40,000 cells/cm 2 
where (S) was [Rh123].
Western blot
Cell supernatant (CS) was collected by aspiration from A549 monolayers which have been incubated with KRB containing 100 μg/ml of nanoparticles for 30 min. Cell lysate (CL) was obtained by washing the cell layers three times with ice-cold phosphate saline buffer (PBS), followed by cell homogenisation in 60 µl per well freshly prepared lysis buffer, containing aprotinin (6%) and leupeptin (1%). Samples of CS and CL were was added for 1 h at room temperature. Peroxidase activity was detected with
Immobilon Western Chemiluminescent HRP substrate (Millipore). Signals were documented using a ChemiDoc system (Bio-Rad).
Analysis of particle size and ζ-potential
Physicochemical properties (i.e., size and ζ-potential) of the nanoparticles were measured before and after the release experiments using a Zetasizer Nano ZS (Malvern, Malvern, UK) at 25°C and a scattering angle of 173°. Nanoparticles were examined immediately after being suspended in KRB (pH 7.4), before initiation of each Rh123 release experiment. To study changes in physicochemical parameters, 800 µl of the supernatant were analysed for size and ζ-potential measurements at the end of the study. The samples containing nanoparticles were placed in a standard disposable capillary cell (DTS1060, Malvern UK) for size measurements and ζ-potential, respectively. Average size was calculated from the intensity, volume and number distributions by Dispersion Technology software 5.03 (Malvern). All measurements were performed in triplicate.
Cell viability assay
The viability of A549 cells was determined by MTT (3-(4, 5-Dimethyl-thiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay. Cells were seeded at a density of 30,000 cells/ cm 2 in 96-well plates and left for 24 h to attach. After 30 min of incubation with nanoparticles (100 μg/ml) suspended in KRB, the cell layers were washed twice with KRB, before 100 μl of fresh KRB and 10 μl of MTT solution (5 mg/ml in KRB) were added to each well. After further incubation at 37°C for 3 h, the supernatant was removed and cells were dispersed in 50 μl DMSO. Absorbance was measured at 570 nm by using a microplate reader (FLUOstar Optima).
Confocal laser scanning microscopy
A549 cell layers were grown on chamber slides at 35,000 cells/ cm 2 for 5 days, before cells were being fixed for 10 min with 2% (w/v) paraformaldehyde and incubated for 10 min in 50 mM NH 4 Cl, followed by permeabilisation for 8 min with 0.1% (w/v)
Triton X-100 in PBS. After 60 min incubation with 200 μl of a 1:500 dilution of monoclonal mouse anti-P-gp antibody, the cell layers were washed three times with PBS, before incubation with 100 μl of a 1:200 dilution of Alexa Fluor 488-conjugated goat anti-mouse F(ab') 2 fragment (Invitrogen) in PBS containing 1% (w/v) BSA.
Propidium iodide (1 μg/ml in PBS) was used to counterstain cell nuclei. In the case of F-actin staining, cells were initially incubated for 30 min with nanoparticles (100 μg/ml) suspended in KRB. TRITC-phalloidin was used at a concentration of 500 ng/ ml in PBS. After 30 min of incubation, the specimens were again washed three times with PBS and embedded in FluorSave anti-fade medium (Merck, Nottingham, UK). Images were obtained using a confocal laser scanning microscope (CLSM, Zeiss LSM 510, Göttingen, Germany) with the instrument's settings adjusted so that no positive signal was observed in the channel corresponding to the fluorescence of the isotypic controls.
Statistical Analysis
Each experiment was repeated at least in triplicate with cells from three different passages. Results were expressed as mean ± SD of at least three experiments. Two groups were compared using using one-way analysis of variance (ANOVA), followed by the Student-Newman-Keuls post hoc test. P < 0.05 was considered as significant.
Results
P-gp expression, localisation and activity in A549 cells
Immunocytochemical staining, performed after 5 days of culture of A549 cell layers, showed moderate expression of P-gp in the plasma membrane (Fig. 1a) . In addition, a punctuate staining pattern typical for intracellular vesicles or similar sub-structures was observed (Fig. 1a) . Consistent with this observation was a moderate signal of immunoreactive P-gp detected by immunoblot (Fig. 1b) .
To investigate P-gp function, A549 cell layers were loaded with Rh123 and the release of the substrate was studied at 37°C and 4°C, as well as in the presence of P-gp inhibitors (i.e., CsA and verapamil) and attenuators of energy dependent translocation events by depletion of ATP (i.e., NaN 3 plus DOG). The difference of fluorescence intensities between the measurements at 37°C and 4°C was calculated (depicted in (Fig. 3) . A similar effect was observed when A549 monolayers were incubated with NaN 3 plus DOG (Fig. 3) .
Rh123 efflux in the presence of nanoparticles
Rh123 release studies were then carried out with insoluble nanoparticles of different sizes and surface charges suspended in the incubation buffer at concentrations of 100 µg/ml. Figure 4 shows the effect of the nanoparticles on Rh123 release from A549 cell layers. Incubation with carboxy (100 nm), amine and sulphate nanoparticles resulted in significantly (P < 0.01 and P < 0.05, respectively) higher intracellular Rh123 levels after 30 min, indicating an attenuating effect on release by inhibition of the P-gp transport system. Carboxy (500 nm) and unmodified latex particles also decreased Rh123 efflux, albeit those effects were not significant (P < 0.05).
Cytotoxicity assay
In order to investigate, if the observed P-gp attenuating effects resulted from cytotoxic events caused by the nanoparticulates, the viability of A549 cells was tested by MTT assay. Cells were incubated with NPs at concentrations of 25, 50 and 100 µg/ml for 30 min (Fig. 5) . Carboxy (500 nm), latex and sulphate particles marginally reduced the cell viability to 79±7%, 78±14% and 84±13%. Amine nanoparticles, however, showed a pronounced and concentration-dependent cytotoxicity, with only 47±1% cell viability at the highest concentration after 30 min. It should be noted that carboxy (100 nm) nanoparticles have been discontinued by the supplier prior to the onset of this study.
Physicochemical characteristics of nanoparticles
Latex nanoparticles with various surface charges, surface modifications and sizes (see Tab. 1) were used in Rh123 release studies. Table 2 shows the changes in ζ-potential and particle size when analysing the NPs before and after release studies.
Prior to experiments, carboxy 100 and 500, latex and sulphate NPs were measured to be negatively charged between with their ζ-potential values ranging from -22 to -63 mV.
Amine-modified particles showed a net positive charge of 61 mV.
The particle sizes measured in our lab were in good agreement with the supplier's given specifications.
Incubation with A549 cell layers resulted in dramatic changes in both particle size and surface charge (Tab. 2). Whilst the ζ-potential was diminished among all nanoparticles, particle size increased significantly as a result of agglomeration. The highest increase was observed for amine-modified particles which grew from approx 50 nm to almost 4 μm in diameter.
Western blot analysis
Nanoparticles suspended in KRB were incubated with A549 cell monolayers for 30 min and the level of P-gp was quantified in the cells and the cell supernatant by Western blot (Fig. 6) . No obvious changes in cellular P-gp levels, compared to control, were observed after incubation with the different nanoparticles (Fig. 6a) . Extraction of P-gp from the membrane into the cell supernatant could also be ruled out, as no protein signals were obtained in the investigated samples (Fig. 6b) .
Confocal laser scanning microscopy
The interactions of nanoparticles with A549 cell layers were measured using confocal laser scanning microscopy ( Fig. 7) . TRITC-labelled phalloidin was used to visualise the cytoskeleton. Agglomerated carboxy and sulphate NPs appeared in the same channel due to their Texas-red label (Fig. 7b, 7e) . It is evident from the CLSM micrographs that none of the nanoparticles were taken up into the cells or caused significant disruption of the cytoskeleton.
Discussion
Consistent with earlier observations [17, 18] , our data confirmed that the A549 cell line functionally expressed P-glycoprotein/MDR1. Rh123 efflux was found to be mediated by a saturable, single transporter site, and an increased accumulation of Rh123 was observed in the presence of verapamil, cyclosporine A and NaN 3 /DOG, agents known to inhibit P-gp function and deplete ATP, respectively.
When studying the interaction of insoluble, latex-based nanoparticles of different surface modification, ζ-potential and particle size with P-gp, we found that Rh123 efflux from A549 cell layers was inhibited in a size and surface-chemistry dependant manner that, in some cases, was of similar scale as the attenuation observed with the pharmacological agents. These findings allow the speculation that nanoparticles might directly interfere with P-gp function. In particular small, carboxylated and sulphated
NPs were able to reduce P-gp-mediated efflux of Rh123 from A549 cells. Whilst similar effects were also observed for amine-modified particles, it cannot be ruled out that this effect resulted from the particles' acute cytotoxicity rather than from direct Pgp inhibition.
Recently, Arvizo et al. [19] reported that gold nanoparticles, depending on their surface charge, caused changes in membrane potential. Nevertheless, P-gp function has repeatedly been observed to be independent of membrane potential [20] . McCarthy and co-workers [21] have shown that when Calu-3 cell monolayers were acutely exposed to carbon nanoparticles, there was an inhibition of forskolin induced I sc activation through CFTR. They concluded that size and charge were essential factors in determining the extent of this effect and that cholesterol and specialised membrane domains at the cell surface play a pivotal role. Thus, a more direct interaction between the nanoparticles and the membrane or even the ABC-transporter can be suggested to be responsible for the observed effects.
We observed that positively charged nanoparticles had the highest cytotoxicity which is consistent with previous reports [19, 22] , whereas negatively charged nanoparticles induced only marginal cell death. Thus, whilst nanoparticles potentially change the conformation of the cell membrane, resulting in a disruption of cellular processes and membrane integrity [23, 24] , most interactions with the cell membrane do not cause any membrane disruption or extraction of the protein from the plasmalemma, as previously observed in the case of cyclodextrins [25] . This was confirmed by Western blot analysis of the cells and their supernatant.
Significant changes in the size of nanoparticles, once they were in contact with the cell supernatant were shown. In most cases, the surface of nanoparticles is covered immediately after contact with biological fluids by several biomolecules [26] . The particles' surface interacts with its dispersion medium in a complex fashion, involving conflictive forces, especially between particles, ions and biological substances in the medium such as proteins. This interplay affects both the hydrodynamic size and the ζ-potential of the nanoparticles and can have an impact on the agglomeration statues of the particle itself [26] .
To further our understanding of nanomedicines, it is necessary to investigate the nanomaterial's physicochemical properties and how these properties influence their uptake and biodistribution. This is the first study comparing pharmacological P-gp inhibitors with nanoparticulates. The attenuation of Rh123 release, and hence, P-gp function by nanoparticles, is an interesting observation, which might further increase the interest in nanoparticulate drug delivery systems, particularly for the treatment of cancer and to overcome biological barriers imposed by efflux pumps, such as Pglycoprotein. Results are expressed as means ± SD (n = 6). 
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